Vedanta gets $60M to finish Phase 3 for C. diff microbiome therapy
Vedanta gets $60M to finish Phase 3 for C. diff microbiome therapy
Vedanta Biosciences
Vedanta Biosciences is a biopharmaceutical company.
Vedanta Biosciences is a biopharmaceutical company.
Vedanta gets $60M to finish Phase 3 for C. diff microbiome therapy